Marc Labroli

1.4k total citations
19 papers, 943 citations indexed

About

Marc Labroli is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Marc Labroli has authored 19 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Infectious Diseases and 4 papers in Organic Chemistry. Recurrent topics in Marc Labroli's work include DNA Repair Mechanisms (5 papers), Cancer therapeutics and mechanisms (5 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). Marc Labroli is often cited by papers focused on DNA Repair Mechanisms (5 papers), Cancer therapeutics and mechanisms (5 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). Marc Labroli collaborates with scholars based in United States. Marc Labroli's co-authors include Dale L. Boger, Qing Jin, Christopher W. Boyce, Clark A. Sehon, Michael P. Dwyer, Timothy J. Guzi, Kamil Paruch, Wolfgang Seghezzi, David Parry and Derek Wiswell and has published in prestigious journals such as Journal of the American Chemical Society, Analytical Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Marc Labroli

19 papers receiving 923 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Labroli United States 11 548 382 161 94 88 19 943
Michel Legraverend France 17 681 1.2× 591 1.5× 172 1.1× 220 2.3× 47 0.5× 53 1.2k
Stanley D. Chamberlain United States 19 476 0.9× 429 1.1× 158 1.0× 177 1.9× 28 0.3× 35 1.0k
Guozhi Tang China 18 242 0.4× 533 1.4× 149 0.9× 71 0.8× 97 1.1× 30 1.0k
Chris Phillips United Kingdom 15 217 0.4× 700 1.8× 98 0.6× 103 1.1× 49 0.6× 20 983
Mark L. Behnke United States 15 605 1.1× 749 2.0× 248 1.5× 208 2.2× 25 0.3× 18 1.4k
Yun He United States 21 918 1.7× 529 1.4× 112 0.7× 133 1.4× 41 0.5× 52 1.5k
Eric Vangrevelinghe Switzerland 16 255 0.5× 349 0.9× 171 1.1× 116 1.2× 35 0.4× 27 859
Jark Böttcher Germany 13 123 0.2× 336 0.9× 126 0.8× 68 0.7× 55 0.6× 23 527
Jiancun Zhang China 25 1.5k 2.6× 631 1.7× 185 1.1× 65 0.7× 35 0.4× 68 2.3k
Wolfgang von der Saal Germany 16 357 0.7× 423 1.1× 101 0.6× 113 1.2× 93 1.1× 35 959

Countries citing papers authored by Marc Labroli

Since Specialization
Citations

This map shows the geographic impact of Marc Labroli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Labroli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Labroli more than expected).

Fields of papers citing papers by Marc Labroli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Labroli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Labroli. The network helps show where Marc Labroli may publish in the future.

Co-authorship network of co-authors of Marc Labroli

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Labroli. A scholar is included among the top collaborators of Marc Labroli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Labroli. Marc Labroli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sanders, John M., Douglas C. Beshore, Joseph Culberson, et al.. (2017). Informing the Selection of Screening Hit Series with in Silico Absorption, Distribution, Metabolism, Excretion, and Toxicity Profiles. Journal of Medicinal Chemistry. 60(16). 6771–6780. 16 indexed citations
2.
Labroli, Marc, John P. Caldwell, Christine Yang, et al.. (2016). Discovery of potent wall teichoic acid early stage inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(16). 3999–4002. 9 indexed citations
3.
Wang, Hao, Marc Labroli, Christine Yang, et al.. (2016). Quantitation of wall teichoic acid in Staphylococcus aureus by direct measurement of monomeric units using LC-MS/MS. Analytical Biochemistry. 518. 9–15. 2 indexed citations
4.
Hou, Yan, Todd Mayhood, Payal R. Sheth, et al.. (2016). NMR Binding and Functional Assays for Detecting Inhibitors of S. aureus MnaA. SLAS DISCOVERY. 21(6). 579–589. 3 indexed citations
5.
Yang, Shu‐Wei, Jianping Pan, Christine Yang, et al.. (2016). Benzimidazole analogs as WTA biosynthesis inhibitors targeting methicillin resistant Staphylococcus aureus. Bioorganic & Medicinal Chemistry Letters. 26(19). 4743–4747. 11 indexed citations
6.
Labroli, Marc, et al.. (2016). A convergent preparation of the CHK1 inhibitor MK-8776 (SCH 900776). Tetrahedron Letters. 57(24). 2601–2603. 4 indexed citations
7.
Labroli, Marc, Michael P. Dwyer, Ruichao Shen, et al.. (2014). The identification of novel 5′-amino gemcitabine analogs as potent RRM1 inhibitors. Bioorganic & Medicinal Chemistry. 22(7). 2303–2310. 10 indexed citations
8.
Dwyer, Michael P., Kamil Paruch, Carmen Álvarez, et al.. (2013). Discovery of pyrazolo[1,5-a]pyrimidine-based Pim inhibitors: A template-based approach. Bioorganic & Medicinal Chemistry Letters. 23(22). 6178–6182. 35 indexed citations
9.
Labroli, Marc, Michael P. Dwyer, Ruichao Shen, et al.. (2013). Syntheses of 5′-amino-2′,5′-dideoxy-2′,2′-difluorocytidine derivatives as novel anticancer nucleoside analogs. Tetrahedron Letters. 55(3). 598–602. 5 indexed citations
10.
Guzi, Timothy J., Kamil Paruch, Michael P. Dwyer, et al.. (2011). Targeting the Replication Checkpoint Using SCH 900776, a Potent and Functionally Selective CHK1 Inhibitor Identified via High Content Screening. Molecular Cancer Therapeutics. 10(4). 591–602. 135 indexed citations
11.
Dwyer, Michael P., Kamil Paruch, Marc Labroli, et al.. (2010). Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach—Part 1. Bioorganic & Medicinal Chemistry Letters. 21(1). 467–470. 55 indexed citations
12.
Labroli, Marc, Kamil Paruch, Michael P. Dwyer, et al.. (2010). Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach—Part 2. Bioorganic & Medicinal Chemistry Letters. 21(1). 471–474. 62 indexed citations
13.
14.
Marsilje, Thomas H., Marc Labroli, Michael P. Hedrick, et al.. (2002). 10-Formyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid (10-Formyl-DDACTHF). Bioorganic & Medicinal Chemistry. 10(8). 2739–2749. 13 indexed citations
15.
Deveau, Amy M., et al.. (2001). The synthesis of amino-acid functionalized β-Carbolines as topoisomerase II inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(10). 1251–1255. 90 indexed citations
16.
Boger, Dale L., Marc Labroli, Thomas H. Marsilje, et al.. (2000). Conformationally restricted analogues designed for selective inhibition of GAR Tfase versus thymidylate synthase or dihydrofolate reductase. Bioorganic & Medicinal Chemistry. 8(5). 1075–1086. 15 indexed citations
17.
Miller, Thomas A., et al.. (1998). The synthesis and evaluation of benzannelated-azatoxins: The benzazatoxins. Bioorganic & Medicinal Chemistry Letters. 8(9). 1065–1070. 10 indexed citations
18.
Boger, Dale L., Christopher W. Boyce, Marc Labroli, Clark A. Sehon, & Qing Jin. (1998). Total Syntheses of Ningalin A, Lamellarin O, Lukianol A, and Permethyl Storniamide A Utilizing Heterocyclic Azadiene Diels−Alder Reactions. Journal of the American Chemical Society. 121(1). 54–62. 350 indexed citations
19.
Zajac, Walter W., et al.. (1994). N-Benzylidenebenzenesulfonamide as a Benzaldehyde Equivalent in the Knoevenagel Reaction. Synthetic Communications. 24(3). 427–432. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michel Legraverend Breakdown of academic impact, for papers by Stanley D. Chamberlain Breakdown of academic impact, for papers by Guozhi Tang Breakdown of academic impact, for papers by Chris Phillips Breakdown of academic impact, for papers by Mark L. Behnke Breakdown of academic impact, for papers by Yun He Breakdown of academic impact, for papers by Eric Vangrevelinghe Breakdown of academic impact, for papers by Jark Böttcher Breakdown of academic impact, for papers by Jiancun Zhang Breakdown of academic impact, for papers by Wolfgang von der Saal
Rankless by CCL
2026